Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nitschmann

Showing results (51-60 of 222) with videos related to

Pageof 23
Sort By:
Der Internist|September 12, 2007
[Influence of diabetes incidence by ramipril and rosiglitazone: DREAM study (diabetes reduction assessment with ramipril and rosiglitazone medication)]E Standl, S Nitschmann
Der Internist|October 13, 2007
[Significance of percutaneous coronary interventions. Results of COURAGE and ICTUS follow-up]S Nitschmann, E Erdmann
Der Internist|October 7, 2020
[Teprotumumab for thyroid-associated ophthalmopathy : OPTIC]R Gärtner, S Nitschmann
Der Internist|September 3, 2014
[Preventive angioplasty in myocardial infarction. Preventive Angioplasty in Acute Myocardial Infarction (PRAMI)]P Kahlert, S Nitschmann
Der Internist|February 6, 2016
[Cancer screening in venous thromboembolism of unknown origin]F Langer, S Nitschmann
Der Internist|November 16, 2014
[Perioperative aspirin treatment in patients undergoing surgery: Perioperative Ischemic Evaluation 2 (POISE-2)]K Schrör, S Nitschmann
Der Internist|October 17, 2012
[Improvement of glomerular filtration rate by intensified insulin therapy : the DCCT and EDIC studies]P Nawroth, S Nitschmann
Innere Medizin (Heidelberg, Germany)|March 24, 2023
[Helicobacter pylori eradication for prevention of ulcer bleeding]C Schulz, S Nitschmann
Innere Medizin (Heidelberg, Germany)|August 4, 2022
[SER-109: oral microbiome therapy for recurrent Clostridioides difficile infections : SER-109 versus Placebo in the Treatment of Adults with Recurrent Clostridium Difficile Infection (ECOSPOR III)]A Stallmach, S Nitschmann
Der Internist|October 26, 2021
[Development of vaccines for prevention of COVID-19 in adolescents]M Augustin, M Hallek, S Nitschmann, et al.
Pageof 23

Showing results (51-60 of 222) with videos related to

Sort By:
Pageof 23
Der Internist|September 12, 2007
[Influence of diabetes incidence by ramipril and rosiglitazone: DREAM study (diabetes reduction assessment with ramipril and rosiglitazone medication)]E Standl, S Nitschmann
Der Internist|October 13, 2007
[Significance of percutaneous coronary interventions. Results of COURAGE and ICTUS follow-up]S Nitschmann, E Erdmann
Der Internist|October 7, 2020
[Teprotumumab for thyroid-associated ophthalmopathy : OPTIC]R Gärtner, S Nitschmann
Der Internist|September 3, 2014
[Preventive angioplasty in myocardial infarction. Preventive Angioplasty in Acute Myocardial Infarction (PRAMI)]P Kahlert, S Nitschmann
Der Internist|February 6, 2016
[Cancer screening in venous thromboembolism of unknown origin]F Langer, S Nitschmann
Der Internist|November 16, 2014
[Perioperative aspirin treatment in patients undergoing surgery: Perioperative Ischemic Evaluation 2 (POISE-2)]K Schrör, S Nitschmann
Der Internist|October 17, 2012
[Improvement of glomerular filtration rate by intensified insulin therapy : the DCCT and EDIC studies]P Nawroth, S Nitschmann
Innere Medizin (Heidelberg, Germany)|March 24, 2023
[Helicobacter pylori eradication for prevention of ulcer bleeding]C Schulz, S Nitschmann
Innere Medizin (Heidelberg, Germany)|August 4, 2022
[SER-109: oral microbiome therapy for recurrent Clostridioides difficile infections : SER-109 versus Placebo in the Treatment of Adults with Recurrent Clostridium Difficile Infection (ECOSPOR III)]A Stallmach, S Nitschmann
Der Internist|October 26, 2021
[Development of vaccines for prevention of COVID-19 in adolescents]M Augustin, M Hallek, S Nitschmann, et al.
Pageof 23